The identification of stem cells in human liver diseases and hepatocellular carcinoma

Experimental and Molecular Pathology

Volumn 88, Issue 3, 2010, Pages 331-340

  Oliva, Joan ^a   French, Barbara A ^a   Qing, X ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

AIR (antisense Igf2r); Epidermal growth factor (EGF); Glutathione S transferase placental (GST P); Hepatocyte growth factor (HGF); O. volvulus 6 (OV 6)

Indexed keywords

CELL PROTEIN; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR; GLUTATHIONE TRANSFERASE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN AIR; PROTEIN FAT10; PROTEIN H19; PROTEIN OV 6; SCATTER FACTOR; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PRIMER DNA;

ADULT; AGED; ALCOHOLIC FATTY LIVER; ARTICLE; CELLULAR DISTRIBUTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER PARENCHYMA; MALE; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; STEM CELL; ADOLESCENT; ADULT STEM CELL; CANCER STEM CELL; FATTY LIVER; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADOLESCENT; ADULT; ADULT STEM CELLS; AGED; BASE SEQUENCE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS;

EID: 77952564300     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.01.003     Document Type: Article

References (36)

1. Alison M.R., et al. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J. Pathol. 2009, 217:282-298.
2. Bottinger E.P., et al. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7, 12-dimethylbenz-[a]-anthracene. Cancer Res. 1997, 57:5564-5570.
3. Burke Z.D., et al. Stem cells in the adult pancreas and liver. Biochem. J. 2007, 404:169-178.
4. Cantz T., et al. Stem cells in liver regeneration and therapy. Cell Tissue Res. 2008, 331:271-282.
5. Chiba T., et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-251.
6. Dabeva M.D., et al. Models for hepatic progenitor cell activation. Proc. Soc. Exp. Biol. Med. 1993, 204:242-252.
7. Dabeva M.D., Shafritz D.A. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am. J. Pathol. 1993, 143:1606-1620.
8. Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956, 16:142-148.
9. Fausto N. Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: present and future. Am. J. Physiol. 1999, 277:G917-G921.
10. Herrera M.B., et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006, 24:2840-2850.
11. Higgins G.M., Anderson R.M. Experimental pathology of the liver. I restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 1931, 12:186-202.
12. Kato A., et al. Relationship between expression of cyclin D1 and impaired liver regeneration observed in fibrotic or cirrhotic rats. J. Gastroenterol. Hepatol. 2005, 20:1198-1205.
13. Kim H., et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J. Hepatol. 2004, 40:298-304.
14. Kothary P.C., et al. Preferential suppression of insulin-stimulated proliferation of cultured hepatocytes by somatostatin: evidence for receptor-mediated growth regulation. J. Cell. Biochem. 1995, 59:258-265.
15. Libbrecht L., et al. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J. Hepatol. 2000, 33:76-84.
16. Lowes K.N., et al. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol. 1999, 154:537-541.
17. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science 1997, 276:60-66.
18. Minuk G.Y. Hepatic regeneration: if it ain't broke, don't fix it. Can. J. Gastroenterol. 2003, 17:418-424.
19. Mishra L., et al. Liver stem cells and hepatocellular carcinoma. Hepatology 2009, 49:318-329.
20. Natarajan A., et al. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17081-17086.
21. Nishino M., et al. Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery 2008, 144:374-384.
22. Oliva J., et al. Heretofore unidentified stem cells in human liver disease. Mol. Biol. Cell 2009, 20. Supplement Abstract 1222.
23. Ridley A.J., et al. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 1988, 7:1635-1645.
24. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006, 25:3818-3822.
25. Roskams T., et al. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J. Hepatol. 1998, 29:455-463.
26. Roskams T.A., et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004, 39:1739-1745.
27. Rountree C.B., et al. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells 2007, 25:2419-2429.
28. Sanz S., et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 2005, 54:134-141.
29. Saxema R., et al. Hepatology. Hepatology: A Textbook of Liver disease 2003.
30. Sell S. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer. Tumour Biol. 2008, 29:161-180.
31. Stefano J.T., et al. Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C. World J. Gastroenterol. 2006, 12:3821-3828.
32. Taub R., et al. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin. Liver Dis. 1999, 19:117-127.
33. Theise N.D., et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999, 30:1425-1433.
34. Thorgeirsson S.S., Grisham J.W. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006, 43:2-8.
35. Weymann A., et al. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 2006, 50:207-215.
36. Xiao J.C., et al. Small epithelial cells in human liver cirrhosis exhibit features of hepatic stem-like cells: immunohistochemical, electron microscopic and immunoelectron microscopic findings. Histopathology 2003, 42:141-149.